Literature DB >> 19908105

Ketamine, but not priming, improves intubating conditions during a propofol-rocuronium induction.

Pelin Traje Topcuoglu1, Sennur Uzun, Ozgur Canbay, Gulsun Pamuk, Saadet Ozgen.   

Abstract

PURPOSE: Both ketamine and priming may shorten the onset time of rocuronium. This study investigates the effects of ketamine and priming as components of a propofol induction on intubating conditions and onset of neuromuscular block.
METHODS: This prospective randomized double-blind study was performed in 120 American Society of Anesthesiologists (ASA) I-II patients who were assigned to one of four groups of 30 patients each: control, priming, ketamine, and ketamine-priming. Ketamine 0.5 mg x kg(-1) or saline was given before priming and induction. Rocuronium 0.06 mg x kg(-1) or saline was injected 2 min before propofol 2.5 mg x kg(-1). This was followed by rocuronium 0.6 mg x kg(-1) or by rocuronium 0.54 mg x kg(-1) if priming was given. Intubation was performed one minute later. Intubating conditions were graded as excellent, good, or poor. Heart rate, noninvasive blood pressure, and train-of-four (TOF) response were monitored.
RESULTS: Intubating conditions were graded excellent in 20% of the control group, 30% of the priming group, 47% of the ketamine group, and 57% of the ketamine-priming group. Analysis using forward stepwise regression indicated that ketamine improved intubating conditions (P = 0.001) but priming did not (P = 0.35). Time to reach a TOF count of zero was shortened by ketamine (P = 0.001) but not by priming (P = 0.94): 216 +/- 20 s in the control group, 212 +/- 27 s in the priming group, 162 +/- 18 s in the ketamine group, and 168 +/- 22 s in the ketamine-priming group.
CONCLUSION: A low-dose ketamine used with a propofol-rocuronium induction improved intubating conditions and shortened onset time. Priming did not influence intubating conditions or onset time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908105     DOI: 10.1007/s12630-009-9217-4

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  7 in total

1.  The effect of ketamine on tracheal intubating conditions without neuromuscular blockade during sevoflurane induction in children.

Authors:  Kyong Sik Kim; Hyun Jeong Kwak; Sang Kee Min; Sook Young Lee; Kyung Mi Kim; Jong Yeop Kim
Journal:  J Anesth       Date:  2011-02-15       Impact factor: 2.078

2.  Influence of Different Doses of Ketamine on Intubating Conditions during a Rapid Sequence Induction and Intubation Model.

Authors:  Başak Ceyda Meço; Ahmet Onat Bermede; Zekeriyya Alanoğlu; Olcay Yaka; Neslihan Alkış
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-02-01

3.  The effect of alfentanil versus ketamine on the intubation condition and hemodynamics with low-dose rocuronium in children.

Authors:  Ji Young Kim; Jong Seok Lee; Hee Yeon Park; Yong Beom Kim; Youngjun Kwon; Hyun Jeong Kwak
Journal:  J Anesth       Date:  2012-09-22       Impact factor: 2.078

4.  Comparison of etomidate and propofol on intubating conditions and the onset time associated with cisatracurium administration.

Authors:  Young-Kwon Ko; Yoon-Hee Kim; Sang-Il Park; Woo Suk Chung; Chan Noh; Jung-Un Lee
Journal:  Korean J Anesthesiol       Date:  2015-03-30

5.  Pharmacological interventions for acceleration of the onset time of rocuronium: a meta-analysis.

Authors:  Jing Dong; Lingqi Gao; Wenqing Lu; Zifeng Xu; Jijian Zheng
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

6.  The effect of low dose ketamine and priming of cisatracurium on the intubating condition and onset time of cisatracurium.

Authors:  Byung-Ryang Ahn; Sang-Hun Kim; Byung-Sik Yu; Kyung-Joon Lim; Jong-June Sun
Journal:  Korean J Anesthesiol       Date:  2012-10-12

7.  Low-Dose Ketamine Pretreatment Reduces the Incidence and Severity of Myoclonus Induced by Etomidate: A Randomized, Double-Blinded, Controlled Clinical Trial.

Authors:  Guan-Nan Wu; Hai-Jun Xu; Fang-Fang Liu; Xian Wu; Hai Zhou
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.